title: Anxiety sensitivity and nonmedical benzodiazepine use among adults with opioid use disorder.
abstract: Nonmedical benzodiazepine use is common among adults with opioid use disorder; however, little is known about this co-occurrence. Anxiety sensitivity-the fear of anxiety symptoms and sensations-motivates behaviors to escape and avoid distressing states, and accordingly is associated with coping motives for substance use. This might be particularly relevant among women, who report using substances to cope with negative emotions more often than men. The aim of the current study was to examine whether nonmedical benzodiazepine use was associated with higher anxiety sensitivity among treatment-seeking adults diagnosed with opioid use disorder, and to investigate whether gender moderated this association. A sample of adults (ranging in age from 18 to 81years) receiving inpatient treatment for opioid use disorder (N=257) completed measures of anxiety, anxiety sensitivity, and benzodiazepine use frequency. Results of an analysis of variance indicated that frequency of past-month nonmedical benzodiazepine use was associated with significantly higher anxiety sensitivity. This effect remained when controlling for the effect of anxiety symptoms (F[1, 251]=3.91, p=0.049, ηp2=0.02). Gender moderated this association, and post-hoc analyses found a strong association between nonmedical benzodiazepine use and anxiety sensitivity in women, and not men. Anxiety sensitivity, which can be reduced with treatment, might be a candidate therapeutic target in this population, particularly in women.
authors: Division of Alcohol and Drug Abuse, McLean Hospital, United States; Department of Psychiatry, Harvard Medical School, United States. Electronic address: kmchugh@mclean.harvard.edu.
authors: R Kathryn
authors: RK
authors: McHugh
authors: Division of Alcohol and Drug Abuse, McLean Hospital, United States.
authors: Victoria R
authors: VR
authors: Votaw
authors: Division of Alcohol and Drug Abuse, McLean Hospital, United States; Department of Psychiatry, Harvard Medical School, United States.
authors: Olivera
authors: O
authors: Bogunovic
authors: Division of Alcohol and Drug Abuse, McLean Hospital, United States.
authors: Sterling L
authors: SL
authors: Karakula
authors: Division of Alcohol and Drug Abuse, McLean Hospital, United States; Department of Psychiatry, Harvard Medical School, United States.
authors: Margaret L
authors: ML
authors: Griffin
authors: Division of Alcohol and Drug Abuse, McLean Hospital, United States; Department of Psychiatry, Harvard Medical School, United States.
authors: Roger D
authors: RD
authors: Weiss
mesh_terms: D000328:Adult; D014151:Anti-Anxiety Agents; D001008:Anxiety Disorders / Q000453:epidemiology* / Q000523:psychology; D001569:Benzodiazepines; D015897:Comorbidity; D005260:Female; D006801:Humans; D008297:Male; D009293:Opioid-Related Disorders / Q000453:epidemiology* / Q000523:psychology* / Q000628:therapy; D063487:Prescription Drug Misuse / Q000523:psychology* / Q000706:statistics & numerical data*; D012737:Sex Factors; D019966:Substance-Related Disorders / Q000453:epidemiology / Q000523:psychology
chemical_list: D014151:Anti-Anxiety Agents; D001569:Benzodiazepines
keywords: Anxiety sensitivity; Benzodiazepines; Gender differences; Opioid use disorder